Skip to content

An Artificial Intelligence Algorithm for Identifying Gynecologic Cancer Patients in Need of Outpatient Palliative Care

Piloting an Artificial Intelligence Algorithm Used to Identify Patients in Need of Outpatient (or Ambulatory) Palliative Care in an Oncology Population

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06182332
Enrollment
221
Registered
2023-12-26
Start date
2023-12-11
Completion date
2024-07-26
Last updated
2025-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced Malignant Female Reproductive System Neoplasm

Brief summary

This clinical trial tests an artificial intelligence (AI) algorithm for its ability to identify patients who may benefit from a palliative care consult for gynecologic cancer that has spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). A significant delay in referral to palliative care often occurs among patients with cancer. This delay can lead to poorer symptom management, decreased quality of life, and care that does not align with patient goals or values. AI algorithms are computer programs that use step-by-step procedures to solve a problem. In this trial, an AI algorithm is applied to patients' medical records in order to identify patients with a high burden of disease. Information gathered from this study may help researchers learn whether this AI algorithm is useful for identifying patients who could benefit from outpatient palliative care consultation.

Detailed description

PRIMARY OBJECTIVE: I. To pilot an oncology risk prediction model to identify patients who may benefit from outpatient palliative care consultation to improve symptom management and goal-concordant care in this population. OUTLINE: Patients' medical records are reviewed for consideration of palliative care consult using AI algorithm once a week (QW) for 6 months.

Interventions

OTHERInternet-Based Intervention

Use AI algorithm

OTHERElectronic Health Record Review

Undergo medical record review

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult patient in Enhanced, Electronic health record (EHR)-facilitated Cancer Symptom Control (E2C2) with a diagnosis of advanced gynecologic malignancy (International Classification of Diseases \[ICD\] codes C51 through C58) * Weekly the reviewers will select patients by looking at patients in sorted order starting with the highest score and proceeding down the list and evaluating each patient for

Design outcomes

Primary

MeasureTime frameDescription
Timely identification for need of palliative careUp to 6 monthsWill be measured as time to the electronic record of consult by the palliative care team in the outpatient setting.

Secondary

MeasureTime frameDescription
Number of palliative care consultationsUp to 6 monthsNumber of palliative care consultations will be assessed as the number of participants who receive palliative care consultations.
Number of advanced care planning notes documented in the electronic health recordUp to 6 monthsParticipant electronic health records will be reviewed for the number of advanced care planning notes listed.
Number of billing codes International Classification of Diseases, 10th Revision for palliative careUp to 6 monthsParticipant electronic health records will be reviewed for the number of International Classification of Diseases, 10th Revision (ICD-10) billing codes for palliative care.
Positive predictive value of screened patientsUp to 6 monthsWill be assessed as the number of patients identified by Artificial Intelligence algorithm who actually received palliative care consultation.
Performance metrics on reviewer/oncologist handoffUp to 6 monthsWill be assessed by agreement statistics and descriptive statistics on time between oncology contact and oncology response.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026